BioMérieux

File:BioMérieux logo.svg

BioM%C3%A9rieux logo

BioMérieux is a multinational biotechnology company founded in 1963 by Alain Mérieux. The company specializes in the field of in vitro diagnostics for medical and industrial applications. BioMérieux is headquartered in Marcy-l'Étoile, France, and operates in over 150 countries worldwide.

History

BioMérieux was established as a subsidiary of the Institut Mérieux, which was founded by Marcel Mérieux, a former student of Louis Pasteur. The company initially focused on the development of diagnostic tools for infectious diseases. Over the years, BioMérieux expanded its product portfolio to include a wide range of diagnostic solutions for various medical conditions and industrial applications.

Products and Services

BioMérieux offers a comprehensive range of products and services in the field of in vitro diagnostics. These include:

• **Microbiology**: Automated systems and culture media for the detection and identification of microorganisms.
• **Immunoassays**: Tests for the detection of antigens and antibodies in various biological samples.
• **Molecular Diagnostics**: Techniques such as polymerase chain reaction (PCR) for the detection of genetic material from pathogens.
• **Industrial Applications**: Diagnostic solutions for the food, pharmaceutical, and cosmetic industries to ensure product safety and quality.

Research and Development

BioMérieux invests significantly in research and development to innovate and improve its diagnostic solutions. The company collaborates with various academic institutions, research organizations, and healthcare providers to advance the field of diagnostics.

Global Presence

BioMérieux operates in over 150 countries, with subsidiaries and production facilities in key regions such as North America, Europe, Asia, and Latin America. The company employs over 12,000 people worldwide and has a strong network of distributors and partners.

Corporate Social Responsibility

BioMérieux is committed to corporate social responsibility (CSR) and sustainability. The company focuses on initiatives that promote public health, environmental protection, and ethical business practices. BioMérieux also supports various global health programs and collaborates with non-governmental organizations to improve access to diagnostics in underserved regions.

See Also

• In vitro diagnostics
• Microbiology
• Immunoassay
• Molecular diagnostics
• Polymerase chain reaction
• Corporate social responsibility